Document is current

Article History

Received: 31 January 2025

Accepted: 13 March 2025

First Online: 6 May 2025

Declarations

:

: Tim Disher, Meaghan Bartlett, Becky Hooper, Jenna Ellis, and Ashley Bonner are current or former employees of EVERSANA. Myrlene Sanon, Dominik Naessen, and Zijiang Yang are employees of Johnson & Johnson and may hold stock/stock options in Johnson & Johnson. Drs. Axel Dignass and Jessica R. Allegretti have received personal compensation from Janssen for consultant fees. Axel Dignass reports fees for participation in clinical trials, review activities such as data monitoring boards, statistical analysis, and endpoint committees from Abivax, AbbVie, Bristol Myers Squibb, Dr Falk Pharma, Galapagos, Gilead, Janssen, and Pfizer; consultancy fees from AbbVie, Amgen, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Celltrion, Dr Falk Foundation, Ferring Pharmaceuticals, Fresenius Kabi, Galapagos, J&J, Lilly, MSD, Pfizer, Pharmacosmos, Sandoz, Stada, Takeda, Tillotts, and Vifor Pharma; payment from lectures including service on speakers bureaus from AbbVie, Biogen, CED Service GmbH, Celltrion, Falk Foundation, Ferring, Galapagos, Gilead, High5MD, Janssen, Materia Prima, MedToday, MSD, Pfizer, Streamed-Up, Takeda, Tillotts, and Vifor Pharma; and payment for manuscript preparation from Falk Foundation, Takeda, Thieme, and UniMed Verlag. Preparation of this manuscript was funded by Janssen.

: This analysis and summary are based on previously completed/published trials and do not contain any new studies with human participants or animals performed by any of the authors.